Celltrion, Inc. Share Price
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
10/11/2026
|
5-day change | 1st Jan Change | ||
| 2,03,000.00 KRW | -3.33% |
|
+6.90% | +17.76% |
| 10/11 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| 03/11 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Market Cap | 46,37200Cr 3.45TCr 3.09TCr 2.85TCr 2.59TCr 4.9TCr 3,23500Cr 5.04TCr 34TCr 14TCr 1,73300Cr 13TCr 13TCr 5,47900Cr | P/E 2026 * |
34.4x | P/E 2027 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.89TCr 3.64Cr 3.27Cr 3.01Cr 2.73Cr 5.17Cr 341.38Cr 5.32Cr 36Cr 14Cr 182.9Cr 14Cr 13Cr 578.2Cr | EV / Sales 2026 * |
8.51x | EV / Sales 2027 * | 7.35x |
| Free-Float |
58.02% | Yield 2026 * |
0.38% | Yield 2027 * | 0.4% |
| 1 day | -3.33% | ||
| 1 week | +6.90% | ||
| Current month | +5.95% | ||
| 1 month | +13.03% | ||
| 3 months | +1.00% | ||
| 6 months | +7.43% | ||
| Current year | +17.76% |
| 1 week | 2,02,000 |  | 2,16,000 |
| 1 month | 1,73,700 | | 2,16,000 |
| Current year | 1,58,500 | | 2,39,047.62 |
| 1 year | 1,58,500 | | 2,39,047.62 |
| 3 years | 1,35,879.99 | | 2,39,047.62 |
| 5 years | 1,14,250.83 | | 2,39,047.62 |
| 10 years | 64,487.59 | | 3,25,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 51 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/01/26 | Sell | 500 | 0.0002% | |||
| 16/01/26 | Sell | 1,000 | 0.0004% | |||
| 16/01/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.33% | +6.90% | +22.78% | +48.07% | 3.45TCr | |
| +0.01% | +11.10% | +60.83% | +70.43% | 6.83TCr | |
| +0.65% | +6.70% | +14.03% | +89.00% | 6.03TCr | |
| -0.11% | -0.15% | +19.50% | +96.84% | 5.59TCr | |
| +1.60% | +19.44% | +28.80% | +112.95% | 4.84TCr | |
| -1.32% | +4.78% | +29.15% | +40.40% | 4.53TCr | |
| -3.54% | -0.60% | +207.76% | +879.50% | 4.18TCr | |
| -0.96% | -1.01% | +84.58% | +56.86% | 3.38TCr | |
| -1.49% | +1.16% | +47.05% | +0.16% | 2.6TCr | |
| +2.92% | +14.41% | -37.74% | +403.12% | 2.62TCr | |
| Average | -0.55% | +6.30% | +47.67% | +179.73% | 4TCr | |
| Weighted average by Cap. | -0.46% | +5.80% | +48.50% | +167.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,75100Cr 427.91Cr 383.75Cr 353.66Cr 321.18Cr 607.87Cr 40TCr 624.83Cr 4.23TCr 1.69TCr 21TCr 1.61TCr 1.57TCr 68TCr | 6,56100Cr 488.19Cr 437.8Cr 403.48Cr 366.43Cr 693.49Cr 46TCr 712.85Cr 4.83TCr 1.92TCr 25TCr 1.83TCr 1.79TCr 78TCr |
| Net income | 1,34100Cr 100Cr 89Cr 82Cr 75Cr 141.77Cr 9.36TCr 145.73Cr 987.6Cr 393.48Cr 5.01TCr 374.53Cr 366.59Cr 16TCr | 1,81400Cr 134.95Cr 121.02Cr 111.54Cr 101.29Cr 191.7Cr 13TCr 197.05Cr 1.34TCr 532.08Cr 6.78TCr 506.46Cr 495.71Cr 21TCr |
| Net Debt | 2,56600Cr 190.89Cr 171.19Cr 157.77Cr 143.28Cr 271.17Cr 18TCr 278.73Cr 1.89TCr 752.63Cr 9.59TCr 716.38Cr 701.19Cr 30TCr | 1,84900Cr 137.58Cr 123.38Cr 113.71Cr 103.27Cr 195.44Cr 13TCr 200.9Cr 1.36TCr 542.46Cr 6.91TCr 516.33Cr 505.38Cr 22TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | ₩2,03,000.00 | -3.33% | 8,69,506 |
| 09/26/09 | ₩2,10,000.00 | -0.47% | 6,26,672 |
| 06/26/06 | ₩2,11,000.00 | -1.86% | 10,36,846 |
| 05/26/05 | ₩2,15,000.00 | +7.50% | 19,99,977 |
| 04/26/04 | ₩2,00,000.00 | +5.32% | 10,91,653 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
